Evidence map›Paper›PMID 39276530›Full record

ArticleStem cell research2024

Generation of a fluorescent mNeonGreen insulin reporter line in the H1 (WA01) hESC background.

Karla F Leavens, Catherine Osorio-Quintero, Elisabeth Ashlyne Yeuteuh, Francesca T Perez-Profeta, Anna Ada Dattoli, Fabian L Cardenas-Diaz, Deborah L French, Paul Gadue

Abstract read
In one paragraph

Article in Stem cell research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karla F LeavensDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania and Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: leavensk@chop.edu.
Catherine Osorio-QuinteroCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Elisabeth Ashlyne YeuteuhDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania and Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Francesca T Perez-ProfetaDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania and Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Anna Ada DattoliCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Fabian L Cardenas-DiazCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biology, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Deborah L FrenchCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Paul GadueCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN).U24DK104162 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI John S. Kaddis, Joyce Carol Niland · 2019 to 2026
$12.3M
Functional Interrogation of T2D-associated genes in human stem cell-derived models and miceUM1DK126194 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GRANT, STRUAN F A, KAESTNER, KLAUS H · 2020 to 2024
$8.8M
Intersection of signaling pathways and transcription factors regulating islet developmentR01DK118155 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI PAUL J GADUE, David Lorberbaum · 2018 to 2026
$4.9M
Career Development Program in Pediatric Diabetes Research (K12) at CHOPK12DK094723 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI WILLI, STEVEN M · 2011 to 2020
$3.6M
Microphysiological systems for modeling autoimmunity in type 1 diabetesUH3DK122644 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GADUE, PAUL J, HUH, DONGEUN · 2021 to 2023
$3.4M
Functional interaction of transcriptional regulators in endocrine lineage specificationR01DK135032 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Maureen A Gannon, DORIS A STOFFERS · 2023 to 2026
$2.8M
Microphysiological systems for modeling autoimmunity in type 1 diabetesUG3DK122644 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GADUE, PAUL J, HUH, DONGEUN · 2019 to 2020
$2.3M
HNF1A in human endocrine cell development and functionR01DK123162 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI GADUE, PAUL J · 2020 to 2023
$2.1M
Dissecting the mechanisms behind biphasic beta cell disease caused by mutations in HNF1alphaK08DK131253 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LEAVENS, KARLA FITZGERALD · 2021 to 2024
$636k
The role of GATA6 and GATA4 in pancreatic beta cell function and developmentF32DK114989 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LEAVENS, KARLA FITZGERALD · 2017 to 2018
$137k
NIDDK NIH HHS F32 DK114989NIDDK NIH HHS K08 DK131253NIDDK NIH HHS K12 DK094723NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK118155NIDDK NIH HHS R01 DK123162NIDDK NIH HHS R01 DK135032NIDDK NIH HHS U24 DK104162NIDDK NIH HHS UG3 DK122644NIDDK NIH HHS UH3 DK122644NIDDK NIH HHS UM1 DK126194
6 · The paper itself

Abstract

Over the past decade, the use of human stem cell-derived β cells (SC-β cells) to model pancreatic β cell development, function and disease has become increasingly common. Though protocols are rapidly improving, current directed differentiation strategies do not yield a pure population of insulin-positive SC-β cells in vitro. Therefore, it is experimentally advantageous to have reporter lines that allow for live sorting of insulin-positive populations. To aid in these studies, we have knocked mNeonGreen fluorescent protein into the endogenous insulin locus of the commonly used H1 (WA01) human embryonic stem cell line.

Indexed as

Genes, ReporterHuman Embryonic Stem CellsInsulinInsulin-Secreting CellsCell DifferentiationCell LineHumansLuminescent ProteinsInsulinLuminescent Proteins

Identifiers

PMID39276530
PMCPMC11719772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.